Back

Context-Dependent Synergism and Antagonism between IGF2BP1/3 and METTL3/14 in m6A-mediated mRNA regulation

Bhardwaj, R.; Bhakhri, H.; Palanichamy, J. K.

2025-05-04 molecular biology
10.1101/2025.05.04.652102 bioRxiv
Show abstract

N-6 Methyl Adenosine (m6A) methylation is primarily found in the 3-UTRs of mRNAs, near the stop codon, and at consensus sequence RRACH. The methylation reaction is catalyzed by RNA methyltransferases METTL3 and METTL14, known as writers. Readers recognize the modified mRNA, which influences mRNA stability and translation. Insulin-like growth factor-2 binding proteins 1 and 3 (IGF2BP1 and IGF2BP3) are known m6A readers, promoting mRNA stabilization. Erasers like ALKBH5 and FTO remove m6A modifications. Dysregulation of m6A machinery has been implicated in cancer progression. We analyzed the expression patterns of writers, erasers, and readers (WERs) in multiple public datasets, including NCBI-GEO, TCGA, TARGET, and normal tissue expression data from GTEx. Our findings revealed widespread dysregulation of WERs across various cancers. To investigate whether IGF2BP1/3 and METTL3/14 function synergistically in mRNA stabilization, we identified direct mRNA targets using intersection analyses of IGF2BP1/3 eCLIP and METTL3/14 knockout (KO) datasets on Galaxy server. This analysis identified METTL14-dependent targets (KDM3B, DYNLL1, CNOT1, RPL29) and METTL3-dependent targets (SREBF2, HNF4A, GNA11), all bound by IGF2BP1/3. To validate these interactions, we cloned 3-UTRs of these targets downstream of luciferase reporter and assessed mRNA stability following IGF2BP1/3 and METTL3/14 overexpression. Luciferase activity increased for RPL29, DYNLL1, SREBF2, and CNOT1 upon co-expression, indicating IGF2BP1/3-mediated mRNA stabilization in an m6A-dependent manner. In contrast, KDM3B, HNF4A, and GNA11 exhibited reduced luciferase activity, suggesting destabilization. Our study provides novel evidence that m6A readers and writers exhibit synergistic and antagonistic interactions in a target-dependent manner, underscoring the complexity of m6A-mediated gene regulation in oncogenesis.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nucleic Acids Research
1128 papers in training set
Top 1%
12.7%
2
Nature Communications
4913 papers in training set
Top 13%
12.7%
3
Cell Reports
1338 papers in training set
Top 4%
8.2%
4
eLife
5422 papers in training set
Top 13%
6.3%
5
iScience
1063 papers in training set
Top 5%
3.6%
6
NAR Cancer
36 papers in training set
Top 0.1%
3.6%
7
PLOS ONE
4510 papers in training set
Top 48%
2.1%
8
Genome Biology
555 papers in training set
Top 3%
2.1%
50% of probability mass above
9
RNA Biology
70 papers in training set
Top 0.2%
1.9%
10
International Journal of Molecular Sciences
453 papers in training set
Top 6%
1.9%
11
PLOS Genetics
756 papers in training set
Top 8%
1.9%
12
Cell Genomics
162 papers in training set
Top 3%
1.7%
13
Scientific Reports
3102 papers in training set
Top 58%
1.7%
14
RNA
169 papers in training set
Top 0.2%
1.7%
15
Molecular Cell
308 papers in training set
Top 7%
1.5%
16
Epigenetics
43 papers in training set
Top 0.5%
1.5%
17
Cells
232 papers in training set
Top 3%
1.5%
18
Communications Biology
886 papers in training set
Top 12%
1.3%
19
Molecular Cancer
14 papers in training set
Top 0.5%
1.2%
20
Computational and Structural Biotechnology Journal
216 papers in training set
Top 6%
1.2%
21
Journal of Molecular Biology
217 papers in training set
Top 3%
1.0%
22
Protein & Cell
25 papers in training set
Top 2%
1.0%
23
BMC Cancer
52 papers in training set
Top 2%
0.9%
24
PLOS Biology
408 papers in training set
Top 16%
0.9%
25
Journal of Genetics and Genomics
36 papers in training set
Top 2%
0.8%
26
Cell Discovery
54 papers in training set
Top 5%
0.8%
27
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
14 papers in training set
Top 0.1%
0.8%
28
Genome Research
409 papers in training set
Top 4%
0.8%
29
The EMBO Journal
267 papers in training set
Top 5%
0.7%
30
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.7%